Biotechnology stocks Index
December 28, 2014 – 11:48 am
iShares Nasdaq Biotechnology Index Fund Stock Quote & Summary Data
Description
The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index (the "Underlying Index"). The Underlying Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals which also meet other eligibility criteria determined by NASDAQ, including minimum market capitalization and liquidity requirements. The Fund generally invests at least 90% of its assets in securities of the Underlying Index and in depositary receipts representing securities of the Underlying Index.
|
| Underlying Index |
NASDAQ Biotechnology Index |
| Management Fee |
0.48 |
Interesting facts
-
Dr. Georgi D. Efremov, (1931-2011) was Macedonian academician and scientist at Macedonian Academy of Sciences and Arts, Skopje, Macedonia and professor from Faculty of Agricultural Science and Food in Skopje. He was specialized in genetic engineering in human medicine, veterinary medicine and animal biotechnology. He was former Ambassador and...
-
Dr. Zoran T. Popovski is a Macedonian scientist and professor working at the Institute of Animal Biotechnology under the Faculty of Agricultural Sciences and Food in the Ss. Cyril and Methodius University, Skopje, Republic of Macedonia. He is a specialist in molecular biology in animal science, genetic engineering and GMO. He has been working...
-
Dr. Georgi D. Efremov, (1931-2011) was Macedonian academician and scientist at Macedonian Academy of Sciences and Arts, Skopje, Macedonia and professor from Faculty of Agricultural Science and Food in Skopje. He was specialized in genetic engineering in human medicine, veterinary medicine and animal biotechnology. He was former Ambassador and...
Related video
Biotech Stock Index BTX Overbought Buy Put Options Nasdaq ...
Biotechnology Stocks BIIB vs CELG Bull Run Time to Short ...
|
|
Biotechnology analyst report: Undervalued biotechnology stock with potential to double: Pick 1 (Biotechnology analyst report: Undervalued biotechnology stocks with potential to double)
eBooks (Vasuda Capital Management, L.L.C.)
|
